Sign Up to like & get recommendations! 0
Published in 2024 at "Brain and Behavior"
DOI: 10.1002/brb3.3527
Abstract: Sequential working memory is the ability to maintain and manipulate sequential information at a second time scale. Patients with progressive supranuclear palsy (PSP) or Parkinson's disease (PD) perform poorly in tests that require the flexible… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.7362
Abstract: Glioblastoma (GB) is the most common malignant primary brain tumor in adults and is associated with a poor prognosis. Current treatment guidelines outline the standard of care for patients with newly diagnosed GB; however, there… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "European journal of cancer"
DOI: 10.1016/j.ejca.2021.06.056
Abstract: INTRODUCTION This prospective, single-arm, phase 2 study assessed the efficacy and safety of lanreotide autogel (LAN) administered at a reduced dosing interval in patients with progressive neuroendocrine tumours (NETs) after LAN standard regimen. METHODS Patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2020.07.127
Abstract: OBJECTIVE A large proportion of patients with atypical parkinsonian syndromes suffer from depression, an antecedent of suicide. This study aimed to explore the prevalence and clinical correlates of suicidal and death ideation (SDI) in patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of cardiovascular computed tomography"
DOI: 10.1016/j.jcct.2018.11.006
Abstract: BACKGROUND We sought to compare quantitative coronary CT angiography (CTA) assessment versus standard clinical reading to identify heart transplanted (HTX) patients with progressive coronary wall thickening. METHODS 35 patients (23 males, age 58 [IQR: 50;61]… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Neurological research"
DOI: 10.1080/01616412.2021.1948768
Abstract: PURPOSE To compare endovascular and drug therapies for efficacy and safety in patients with a progressive stroke caused by intracranial large vascular occlusion exceeding the time window of 24 hours. PATIENTS AND METHODS A total of… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "European Journal of Neurology"
DOI: 10.1111/ene.70080
Abstract: This study aimed to explore the associations between inflammatory markers and the severity of early neurological dysfunction and prognosis in patients with progressive stroke (PS) and evaluated the predictive value of inflammatory markers for PS. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Respirology"
DOI: 10.1111/resp.14452
Abstract: In the INBUILD trial in patients with progressive fibrosing interstitial lung diseases (ILDs), nintedanib reduced the rate of decline in forced vital capacity (FVC) with an adverse event profile characterized mainly by gastrointestinal events. We… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Ophthalmology"
DOI: 10.1155/2019/8285649
Abstract: Purpose The purpose of the current study was to evaluate the long-term functional results based on keratometric measurements, spherical and cylinder equivalent in patients with progressive keratoconus treated with conventional “epi-off” corneal collagen cross-linking (CXL).… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Intensive Care Medicine"
DOI: 10.1177/0885066617748874
Abstract: Background: Data on the outcomes of intensive care unit (ICU) admissions for patients with advanced incurable chemoresistant solid tumor malignancies, and the benefits of subsequent/post-ICU anticancer treatments are limited but have end-of-life and ethical implications.… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "BMC Pulmonary Medicine"
DOI: 10.1186/s12890-024-03314-0
Abstract: The Myositis Interstitial Lung Disease Nintedanib Trial (MINT) is a hybrid trial, which is enrolling patients both at local sites and remotely via a decentralised site. The trial will investigate the efficacy and safety of… read more here.